0
Editor's Correspondence |

Adverse Events in Patients Receiving Cholinesterase Inhibitors Due to Dissimilar Follow-up Periods—Reply

Sudeep S. Gill, MD, MSc; Chaim M. Bell, MD, PhD; Paula A. Rochon, MD, MPH
Arch Intern Med. 2009;169(18):1718-1725. doi:10.1001/archinternmed.2009.348.
Text Size: A A A
Published online

Extract

In reply

We thank Dr Chan for his interest in our study,1 and we agree that cholinesterase inhibitors may provide clinical benefits for some patients with Alzheimer disease. The goal of our study was to better characterize underrecognized adverse effects of these medications. Dr Chan highlights the shorter mean follow-up time among cholinesterase inhibitor users compared with nonusers in our study, which was detailed in Table 3 of our article.1 These findings are similar to those in randomized trials, in which it has been consistently demonstrated that there is a higher dropout rate for patients assigned to treatment with cholinesterase inhibitors than for patients assigned to placebo.2 Clinical experience supports this observation, which appears to be due primarily to adverse drug effects such as nausea and diarrhea. Thus, the patients who used cholinesterase inhibitors in our study had less opportunity to develop syncope-related outcomes compared with the control subjects. As a result, the number of events per 1000 person-years provides a more accurate reflection of harm than do crude event rates. Nonetheless, we presented both figures in Table 3.1

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 26

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();